High Density Lipoproteins

In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation.

The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

Summarizes latest results of the European network on HDL Broadens your understanding of both clinical and molecular biology issues relevant to HDL Gives insight into latest treatments of HDL Includes supplementary material: sn.pub/extras

Texte du rabat

In this Handbook of Experimental Pharmacology on High Density Lipoproteins from biological understanding to clinical exploitation contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

Contenu
Preface.- Part 1. Physiology of HDL.- Part 2. Pathology of HDL.- Part 3. Possible Indications and Target Mechanisms of HDL Therapy.- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.